Role of appendix and spleen in experimental colitis

Area of Science:

• Immunology
• Gastroenterology
• Inflammatory Bowel Disease Research

Background:

• Growing evidence suggests secondary lymphoid tissues contribute to ulcerative colitis (UC).
• The roles of specific tissues like the appendix and spleen in UC initiation and progression require further investigation.

Purpose of the Study:

• To experimentally assess the contribution of the appendix and spleen to the development of colitis.
• To determine if surgical removal of these lymphoid tissues impacts colitis severity.

Main Methods:

• Colitis was induced in mice using 2.5% dextran sodium sulfate (DSS) in drinking water for 7 days.
• Mice underwent sham operation, appendectomy, or combined appendectomy/splenectomy prior to DSS administration.
• Disease activity was evaluated via weight loss, stool consistency, rectal bleeding, white blood cell count, hematocrit, and colonic myeloperoxidase (MPO) activity.

Main Results:

• Appendectomy, alone or combined with splenectomy, delayed the onset and reduced the severity of DSS-induced colitis.
• Histological analysis showed significantly lower colonic damage scores and reduced ulcerated mucosal surface area in appendectomized mice.
• Colonic MPO activity, a marker of inflammation, was lowest in mice lacking the appendix, correlating with reduced tissue injury.

Conclusions:

• Appendicular lymphoid tissue, but not splenic tissue, significantly contributes to the development of experimental colitis.
• Targeting appendicular lymphoid tissue may represent a potential therapeutic strategy for ulcerative colitis.